Pozen shareholders narrowly pass executive pay package amid questions of fairness

After a “say on pay” proposal barely passed approval from Pozen shareholders, the chairman of the pharmaceutical company’s compensation committee put pen to paper to explain to shareholders why executives in general, and CEO John Plachetka specifically, are compensated “fairly” and why giving them fair compensation is “in the best interest of shareholders...